Stay updated on MK-3475 and Gemcitabine in NSCLC Clinical Trial
Sign up to get notified when there's something new on the MK-3475 and Gemcitabine in NSCLC Clinical Trial page.

Latest updates to the MK-3475 and Gemcitabine in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded recruitment status notice (No longer looking for participants) and new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) along with updating the Intervention label to 'Intervention/Treatment' and the page revision to v3.6.0; the older label 'Intervention / Treatment' and revision 'v3.5.5' were removed.SummaryDifference0.5%

- Check21 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, representing a minor update to the page's template or documentation without changing study content.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4. This indicates a minor update to the page metadata and does not modify substantive study content.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision tag v3.5.3 was added, replacing the previous v3.5.2. This indicates an update to the study documentation on the page.SummaryDifference0.1%

- Check71 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2. This change does not modify study details or user-facing functionality.SummaryDifference0.1%

- Check92 days agoChange DetectedAdded site revision tag v3.5.0 and removed revision tag v3.4.3.SummaryDifference0.1%

Stay in the know with updates to MK-3475 and Gemcitabine in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-3475 and Gemcitabine in NSCLC Clinical Trial page.